Windtree Therapeutics Stock (NASDAQ: WINT) stock price, news, charts, stock research, profile.
Open | $3.13 |
Close | - |
Volume / Avg. | 451.62K / 1.32M |
Day Range | $3.13 - $3.46 |
52 Wk Range | 2.75 - 27.00 |
Market Cap | $5.15M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 36 |
Short Interest | 6.55% |
Days to Cover | 2.89 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Windtree Therapeutics (NASDAQ:WINT) through any online brokerage.
Other companies in Windtree Therapeutics’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Eterna Therapeutics (NASDAQ:ERNA), Alzamend Neuro (NASDAQ:ALZN), Virios Therapeutics (NASDAQ:VIRI) and Synaptogenix (NASDAQ:SNPX).
Windtree Therapeutics has a consensus price target of $1.00.
The stock price for Windtree Therapeutics (NASDAQ: WINT) is $3.4 last updated September 23, 2024 at 3:46 PM EDT.
There are no upcoming dividends for Windtree Therapeutics.
Windtree Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Windtree Therapeutics.
Windtree Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.